glp-1 shortage news today november 2025 Orforglipron, an Oral Small-Molecule Receptor Agonist for Obesity 5, DOI: 10.1056/NEJMdo008238 New for the treatment of obesity - and so many additional indications being studied GLP-1 Receptor Agonist Market Growth
Pay in 4 interest-free payments of $5.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4



















